Cn thay i nhng thi quen xu c ln da khe mnh t bn trong
Observational studies have reported that weight-loss interventions are associated with reduced circulating prolactin levels, whereas dopamine agonists, which suppress prolactin secretion, improve metabolic and endocrine abnormalities in patients with established hyperprolactinemia
This means your body becomes used to it, and stopping too quickly can cause withdrawal symptoms
This is the same mechanism that causes the initial "water weight" when starting creatine but in the context of GLP-1 therapy, maintaining intracellular hydration is a feature, not a bug
Finally, the treatment effect of GLP-1RAs on the hospitalization for HF was consistently neutral across the trials [2, 3, 28, 29]
This tailored approach helps minimize side effects and supports long-term, sustainable outcomes